close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Colossal Biosciences

News headline image
Colossal Biosciences Hatches Live Chicks from Fully Artificial Eggs, Advancing the Path to Moa De-Extinction
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Adds the Iconic Bluebuck to Its De-Extinction Portfolio
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Celebrates the First Birthday of Romulus & Remus
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion
From Colossal Biosciences
Via Business Wire
News headline image
World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer
From Colossal Biosciences
Via Business Wire
News headline image
The Ngāi Tahu Research Centre Has Entered Into a Strategic Partnership With De-Extinction Company, Colossal Biosciences, and Sir Peter Jackson, to Resurrect the South Island Giant Moa and Other Taonga Species
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Launches The Colossal Foundation
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
From Colossal Biosciences
Via Business Wire
News headline image
Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding
From Colossal Biosciences
Via Business Wire
News headline image
Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink of extinction
From Colossal Biosciences
Via Business Wire
News headline image
World-Renowned Ancient DNA Expert, HHMI Investigator, and MacArthur Award Winner Beth Shapiro, Ph.D., Joins Colossal as Chief Science Officer
From Colossal Biosciences
Via Business Wire
News headline image
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
From Colossal Biosciences
Via Business Wire
News headline image
Oscar-Award Winning ‘My Octopus Teacher’ Nature Documentarian James Reed to Make Docuseries About De-Extinction Company Colossal, to be Produced by Underdog Films and Teton Ridge Entertainment
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Names Emily Castel as Chief Marketing Officer
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Announces the Tasmania Thylacine Advisory Committee
From Colossal Biosciences
Via Business Wire
News headline image
Mauritian Wildlife Foundation Partners With Colossal Biosciences to Rewild the Dodo to Its Native Habitat
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences and Save the Elephants Debut First-of-its-Kind Project to Utilize Drones and Machine Learning for Elephant Conservation
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences “Mammoth in the Classroom” Initiative, as Part of University of Alaska Fairbanks Adopt a Mammoth Program, Has Reached Its Initial Research and Adoption Goal
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Launches Partnership with Elephant Havens Wildlife Foundation to Develop New Models for the Successful Reintroduction of Orphan Elephants Using AI
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Named to TIME’s List of the TIME100 Most Influential Companies
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction
From Colossal Biosciences
Via Business Wire
News headline image
Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences
From Colossal Biosciences
Via Business Wire
News headline image
Colossal to De-Extinct the Thylacine, also known as the Tasmanian Tiger, an Iconic Australian Marsupial That Has Been Extinct Since 1936
From Colossal Biosciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today